Anondita Medicare Ltd
Founded in March 2024, Anondita Medicare Limited manufactures flavored male condoms, with its flagship product branded as “COBRA.”[1]
- Market Cap ₹ 2,095 Cr.
- Current Price ₹ 1,100
- High / Low ₹ 1,310 / 316
- Stock P/E 78.1
- Book Value ₹ 59.5
- Dividend Yield 0.00 %
- ROCE 39.6 %
- ROE 37.9 %
- Face Value ₹ 10.0
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 44.3%
Cons
- Stock is trading at 18.5 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Fast Moving Consumer Goods Fast Moving Consumer Goods Personal Products Personal Care
Part of Nifty SME Emerge
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 1m | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| 0 | 61 | 112 | |
| 0 | 43 | 72 | |
| Operating Profit | 0 | 18 | 39 |
| OPM % | 30% | 35% | |
| 0 | 0 | 2 | |
| Interest | 0 | 3 | 3 |
| Depreciation | 0 | 1 | 1 |
| Profit before tax | 0 | 14 | 37 |
| Tax % | 25% | 27% | |
| 0 | 11 | 27 | |
| EPS in Rs | 0.00 | 7.71 | 14.12 |
| Dividend Payout % | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 85% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 148% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 247% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 44% |
| Last Year: | 38% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Equity Capital | 0.10 | 13 | 18 |
| Reserves | 0 | 15 | 95 |
| 0 | 27 | 33 | |
| 0 | 9 | 17 | |
| Total Liabilities | 0 | 64 | 163 |
| 0 | 13 | 81 | |
| CWIP | 0 | 6 | 0 |
| Investments | 0 | 4 | 4 |
| 0 | 41 | 79 | |
| Total Assets | 0 | 64 | 163 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| -0 | 6 | 4 | |
| 0 | -23 | -61 | |
| 0 | 17 | 67 | |
| Net Cash Flow | 0 | 0 | 9 |
| Free Cash Flow | -0 | -14 | -59 |
| CFO/OP | 36% | 18% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Debtor Days | 100 | 124 | |
| Inventory Days | 115 | 101 | |
| Days Payable | 45 | 59 | |
| Cash Conversion Cycle | 170 | 166 | |
| Working Capital Days | 101 | 140 | |
| ROCE % | 62% | 40% |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Annual Production Volume lakhs pieces |
|
|||
| Capacity Utilization Rate % |
||||
| Installed Production Capacity lakhs pieces |
||||
| Number of Distributors number |
||||
| Number of Retailers number |
||||
| Number of Super Stockists number |
||||
| Total Manufacturing Lines number |
||||
Extracted by Screener AI
Documents
Announcements
-
Copy of Newspaper Publication
- Published AGM notice ads in Financial Express and Jansatta; AGM on September 29, 2026.
-
Press Release
- Anondita Medicare declared L1 bidder for CMSS tender to supply 8,00,62,000 condoms.
-
Updates
- Declared L1 bidder by CMSS for 8,00,62,000 condoms tender.
-
Updates
- Anondita Medicare proposes rights issue of 9,58,000 shares up to ₹91.01 crore; record date September 2, 2026.
-
Appointment
- Board appointed M/s Bahadur Murao & Co. as cost auditor for FY 2026-27.
Annual reports
No data available.
Concalls
-
Jun 2026TranscriptAI SummaryPPT
-
May 2026Transcript PPT
-
Mar 2026TranscriptAI SummaryPPT
Business Profile:[1]
Anondita Medicare manufactures male (and recently, female) condoms, flagship brand “COBRA,” with in-house printing/packaging and 100% electronic testing.